Recall Register

Food, drugs, devices › Walmart Inc

Drug recall: Artri King Reforzado con Ortiga Omega 3 Tablets, ORIGINAL, 100-count bottles, Melchor Ocampo No. 55 Local D, Delegacion

FDA enforcement event 90359 · Class I · initiated 24 May 2022 · status Completed

DrugVoluntary: Firm initiated3 product recordsBentonville, AR

FDA enforcement event 90359 is a drug recall by Walmart Inc of Bentonville, AR, initiated 24 May 2022 and classified Class I, with 3 product records.

FDA defines Class I as a situation in which there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death. 18% of the 325 drug enforcement events initiated in 2022 carry the same class.

Status: Completed. Initiation: voluntary: firm initiated. Walmart Inc has 4 enforcement events on this register, with a median of 2 product records per event.

Recall classification reflects the relative degree of health hazard. Text in quotation marks is FDA's. openFDA export dated 28 Sep 2026.

Recalling firm

Walmart Inc, Bentonville, AR.

Reason for recall

"Marketed Without An Unapproved NDA/ANDA: Product lot found to be tainted with undeclared diclofenac, an FDA approved nonsteroidal anti-inflammatory drug (NSAID) for the treatment of pain and inflammation."

Distribution

"Nationwide in the USA."

Product records

Recall numberProductQuantityClassStatusReport date
D-1157-2022Artri King Reforzado con Ortiga Omega 3 Tablets, ORIGINAL, 100-count bottles, Melchor Ocampo No. 55 Local D, Delegacion Xochimilco, C.P. 16800, Mexico, D.F., UPC 7 501031 111190.1308 bottles totalClass ICompleted22 Jun 2022
D-1158-2022Artri Ajo King Reforzado con Ortiga y Omega 3 Tablets, ORIGINAL, 100-count bottles, UPC 7 501031 12705.1308 bottles totalClass IICompleted22 Jun 2022
D-1159-2022Artri King Reforzado con Ortiga Omega 3 Tablets, ORIGINAL, a) 100-count bottles labeled with UPC 7 501031 111190 and UPC 6 09002 40885, and b) 2 pack of 100-count bottles per carton UPC 3 72426 014341308 bottles totalClass IICompleted22 Jun 2022

Context

18%of 2022 drug events are Class I325 events that year
3product records in this eventfirm median: 2
4events on this register for the firm

Other enforcement events for Walmart Inc

InitiatedProduct (first record)TypeClassRecords
20 May 2025Fresh cut cucumber slices, Marketside, packaged in clear plastic circular container with clear plastic lid and white adhFoodClass I1
28 Nov 2024Marketside Fresh Cut Cucumber Slices. In clear deli plastic container with lid. Weights vary. Perishable. Keep RefrigeraFoodClass I1
26 Sep 2024Great Value Diced Peaches, Mandarin Segments, & Cherry Mixed Fruits Variety Pack, 4 oz, 12 PackFoodClass III2

All 4 events for Walmart Inc

Questions and answers

Why was this drug recalled?

FDA's record gives the reason for recall as: "Marketed Without An Unapproved NDA/ANDA: Product lot found to be tainted with undeclared diclofenac, an FDA approved nonsteroidal anti-inflammatory drug (NSAID) for the treatment of pain and inflammation."

What does Class I mean?

FDA classifies recalls by relative degree of health hazard. Class I is a situation in which there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death.

Where was the product distributed?

FDA's distribution pattern field reads: "Nationwide in the USA."

Is the recall still ongoing?

FDA lists the status as Completed. "Terminated" means FDA has determined that all reasonable efforts to remove or correct the product have been made.

Where does this data come from?

openFDA enforcement reports (food, drug and device), CC0, export dated 28 Sep 2026. Text in quotation marks is FDA's. The FDA enforcement report linked above is authoritative.

Provenance

Source: openFDA drug enforcement reports (CC0), export dated 28 Sep 2026; records grouped by FDA event number. The class shown for the event is the most severe class among its records. Errors in processing are corrected at the next build; see corrections.